BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 36388651)

  • 1. Identification of a chemotherapy-associated gene signature for a risk model of prognosis in gastric adenocarcinoma through bioinformatics analysis.
    Shen Y; Chen K; Gu C
    J Gastrointest Oncol; 2022 Oct; 13(5):2219-2233. PubMed ID: 36388651
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Construction of mRNA prognosis signature associated with differentially expressed genes in early stage of stomach adenocarcinomas based on TCGA and GEO datasets.
    Jiang F; Lin H; Yan H; Sun X; Yang J; Dong M
    Eur J Med Res; 2022 Oct; 27(1):205. PubMed ID: 36253873
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Construction of a novel mRNA-signature prediction model for prognosis of bladder cancer based on a statistical analysis.
    Li J; Cao J; Li P; Yao Z; Deng R; Ying L; Tian J
    BMC Cancer; 2021 Jul; 21(1):858. PubMed ID: 34315402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. A nomogram model based on the number of examined lymph nodes-related signature to predict prognosis and guide clinical therapy in gastric cancer.
    Li H; Lin D; Yu Z; Li H; Zhao S; Hainisayimu T; Liu L; Wang K
    Front Immunol; 2022; 13():947802. PubMed ID: 36405735
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Single-cell data revealed CD14-type and FCGR3A-type macrophages and relevant prognostic factors for predicting immunotherapy and prognosis in stomach adenocarcinoma.
    Li M; Lu M; Li J; Gui Q; Xia Y; Lu C; Shu H
    PeerJ; 2024; 12():e16776. PubMed ID: 38274323
    [TBL] [Abstract][Full Text] [Related]  

  • 6. A 9‑gene expression signature to predict stage development in resectable stomach adenocarcinoma.
    Liu Z; Liu H; Wang Y; Li Z
    BMC Gastroenterol; 2022 Oct; 22(1):435. PubMed ID: 36241983
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Identification of prognostic gene signature associated with microenvironment of lung adenocarcinoma.
    Yue C; Ma H; Zhou Y
    PeerJ; 2019; 7():e8128. PubMed ID: 31803536
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Angiogenesis-related lncRNAs predict the prognosis signature of stomach adenocarcinoma.
    Han C; Zhang C; Wang H; Li K; Zhao L
    BMC Cancer; 2021 Dec; 21(1):1312. PubMed ID: 34876056
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Prognostic value of RNA methylation-related genes in gastric adenocarcinoma based on bioinformatics.
    He X; Chen X; Yang C; Wang W; Sun H; Wang J; Fu J; Dong H
    PeerJ; 2024; 12():e16951. PubMed ID: 38436027
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Construction of a prognostic risk model for Stomach adenocarcinoma based on endoplasmic reticulum stress genes.
    Li X; Lei Y
    Wien Klin Wochenschr; 2024 Jun; 136(11-12):319-330. PubMed ID: 37993598
    [TBL] [Abstract][Full Text] [Related]  

  • 11. A novel prognostic gene set for colon adenocarcinoma relative to the tumor microenvironment, chemotherapy, and immune therapy.
    Zhou H; Wang Y; Zhang Z; Xiong L; Liu Z; Wen Y
    Front Genet; 2022; 13():975404. PubMed ID: 36699444
    [No Abstract]   [Full Text] [Related]  

  • 12. A ubiquitination-related risk model for predicting the prognosis and immunotherapy response of gastric adenocarcinoma patients.
    Shao S; Sun Y; Zhao D; Tian Y; Yang Y; Luo N
    PeerJ; 2024; 12():e16868. PubMed ID: 38313020
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Identification of a three-gene expression signature and construction of a prognostic nomogram predicting overall survival in lung adenocarcinoma based on TCGA and GEO databases.
    Zhou Y; Gao S; Yang R; Du C; Wang Y; Wu Y
    Transl Lung Cancer Res; 2022 Jul; 11(7):1479-1496. PubMed ID: 35958325
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Comprehensive
    Xu T; Xu W; Zheng Y; Li X; Cai H; Xu Z; Zou Q; Yu B
    Front Immunol; 2022; 13():931906. PubMed ID: 35958598
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Identification of critical prognosis signature associated with lymph node metastasis of stomach adenocarcinomas.
    Wang X; Zhang W; Guo Y; Zhang Y; Bai X; Xie Y
    World J Surg Oncol; 2023 Feb; 21(1):61. PubMed ID: 36823639
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A 13-Gene Metabolic Prognostic Signature Is Associated With Clinical and Immune Features in Stomach Adenocarcinoma.
    Ye Z; Zheng M; Zeng Y; Wei S; Huang H; Wang Y; Liu Q; Lin Z; Chen S; Zheng Q; Chen L
    Front Oncol; 2021; 11():612952. PubMed ID: 34235071
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification and validation of a novel angiogenesis-related gene signature for predicting prognosis in gastric adenocarcinoma.
    Xu P; Liu S; Song S; Yao X; Li X; Zhang J; Liu Y; Zheng Y; Gao G; Xu J
    Front Oncol; 2022; 12():965102. PubMed ID: 36727080
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Identification and validation of an individualized autophagy-clinical prognostic index in gastric cancer patients.
    Qiu J; Sun M; Wang Y; Chen B
    Cancer Cell Int; 2020; 20():178. PubMed ID: 32477008
    [TBL] [Abstract][Full Text] [Related]  

  • 19. 5-mRNA-based prognostic signature of survival in lung adenocarcinoma.
    Xia QL; He XM; Ma Y; Li QY; Du YZ; Wang J
    World J Clin Oncol; 2023 Jan; 14(1):27-39. PubMed ID: 36699627
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Mitochondrial-Related Transcriptome Feature Correlates with Prognosis, Vascular Invasion, Tumor Microenvironment, and Treatment Response in Hepatocellular Carcinoma.
    Wang Y; Song F; Zhang X; Yang C
    Oxid Med Cell Longev; 2022; 2022():1592905. PubMed ID: 35535359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.